HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 08, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 938.5 as of 08 Aug 14:20.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 38.3 on March 2025 . This represents a CAGR of 17.71% over 6 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25253 crore on March 2025 . This represents a CAGR of 36.36% over 6 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Jun '25 is ₹ 1717 crore as compare to the Mar '25 revenue of ₹ 1783 crore. This represent the decline of -3.73% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Jun '25 is ₹ 1108 crore as compare to the Mar '25 revenue of ₹ 963.96 crore. This represent the growth of 14.99%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Jun '25 is ₹ 287.4 crore as compare to the Mar '25 ebitda of ₹ 285.45 crore. This represent the growth of 0.68% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Jun '25 is ₹ 315.42 crore as compare to the Mar '25 ebitda of ₹ 240.92 crore. This represent the growth of 30.92%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 153.63 crore over 9 quarters. This represents a CAGR of 11.36% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 202.38 crore over 9 quarters. This represents a CAGR of 16.94% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 36.98 % on March 2025 . This represents a CAGR of 2.60% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma Q1 PAT jumps 14% YoY to Rs 157 cr

Revenue from operations grew 9.54% year on year (YoY) to Rs 1,710.72 crore in the quarter ...

Read more

05 Aug 2025 14:53

News

Alembic Pharmaceuticals receives USFDA approval for Carbamazepine Extended-Release Tablets

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

26 Jul 2025 13:46

News

Alembic Pharmaceuticals to convene board meeting

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 ...

Read more

21 Jul 2025 17:03

News

Alembic Pharmaceuticals appoints Sr. Vice President - SCM & Operations

Alembic Pharmaceuticals has appointed Dr. Sachin Ghosalkar is appointed as Sr. Vice Presid...

Read more

21 Jul 2025 14:08

News

Alembic Pharma appoints G. Krishnan as new CFO

Krishnan is a seasoned finance professional with over 22 years of experience across the ph...

Read more

07 Jul 2025 14:58

News

Alembic Pharmaceuticals announces acquisition of Utility Therapeutics

Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acqui...

Read more

03 Jul 2025 09:15

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals Ltd eases for fifth straight session

J B Chemicals & Pharmaceuticals Ltd dropped for a fifth straight session today. The stock ...

Read more

05 Aug 2025 13:35

News

JB Chemicals Q1 PAT jumps 14% YoY to Rs 202 cr

Profit before tax (PBT) stood at Rs 271.61 crore in Q1 FY26, rising 13.25% from the Rs 239...

Read more

31 Jul 2025 11:27

News

J B Chemicals & Pharmaceuticals Ltd soars 1.07%, up for fifth straight session

J B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock...

Read more

25 Jul 2025 13:00

News

J B Chemicals & Pharmaceuticals to discuss results

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 2025 10:13

News

J B Chemicals & Pharmaceuticals to conduct AGM

J B Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the comp...

Read more

12 Jul 2025 09:53

News

J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group

Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Fina...

Read more

30 Jun 2025 15:00

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 18,677 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 26,394 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of August 8, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹950.2. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1688.5.

How do dividend payouts of Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions